Feb. 3 at 9:32 PM
$TSOI Building a Scalable Model
TimGDixon
Dec 10, 2022
“we never talk about bringing more shareholder value? Is that a correct narrative? Let's see what we've done lately.
Res Nova Bio whom we have licensed the indication of breast cancer and sold them our IND for
$200K and a patent licensing fee of
$50,000 + annual minimum royalty of
$10,000 + 10% of future revenue.
Breathe Biologics whom we have licensed the indication of COPD and sold them IND for
$200K and a patent licensing fee of
$50,000 + annual minimum royalty of
$10,000 + 10% of future revenue.
Campbell Neurosciences whom we have licensed 11 patents to them for their programs. Just yesterday TSOI collected on licensing fees and opted to take more stock in Campbell increasing our holdings by 660,000 shares of common at
$1.00 a share for a total of 15,660,000.”
Cont. in comments….
